Medium urgency

Panel advances bill to regulate ‘deeply problematic’ AI in psychotherapy - MN House of Representatives (.gov)

Detected August 18, 2026 · in Healthcare AI Regulation (FDA / ONC)

Minnesota House panel advances a bill to regulate AI in psychotherapy, citing it as 'deeply problematic.' The bill's specifics are not yet detailed in the excerpt.

Aforeworn detected this change in the Healthcare AI Regulation (FDA / ONC) space on August 18, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Health systems, medical device companies, health tech startups, and digital health compliance teams developing or using AI in psychotherapy in Minnesota. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the excerpt.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Healthcare AI Regulation (FDA / ONC) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

A Minnesota House panel has advanced a bill to regulate AI in psychotherapy, signaling upcoming legislative changes.

Who it affects

Health systems, medical device companies, health tech startups, and digital health compliance teams developing or using AI in psychotherapy in Minnesota.

What you must do

Monitor the bill's progress and prepare for potential compliance requirements.

Deadline

Not specified in the excerpt.

Source: https://news.google.com/rss/articles/CBMiXkFVX3lxTFB5emk3N3BIdmVJTHZtMUVzYUxMVXp5bG9MRkdmekR3ZFBPOEg0bzVpbGFTajBRNE1DVjJnMWF2R2NkaXpNeWxXdjhXX3NSV3VDRHhxU1FTcXdaZE84bVE?oc=5

Never miss a change like this again

Aforeworn watches Healthcare AI Regulation (FDA / ONC) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Healthcare AI Regulation (FDA / ONC)